Yat Sun Or
Known title: Sr. VP & CSOCIK: 0001571212
Associated companies
Transaction History
| ENTA | ▲ Buy | Grant | 1,650 | $0 | 2/12/2026 | View on chart |
| ENTA | ▲ Buy | Grant | 5,225 | $0 | 2/12/2026 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 3,413 | $49K | 2/12/2026 | View on chart |
| ENTA | ▼ Sell | Open Market | 2,390 | $34K | 12/5/2025 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 753 | $11K | 12/1/2025 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 4,324 | $24K | 2/12/2025 | View on chart |
| ENTA | ▲ Buy | Grant | 9,750 | $0 | 2/12/2025 | View on chart |
| ENTA | ▼ Sell | Open Market | 2,591 | $21K | 12/6/2024 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 1,595 | $14K | 12/1/2024 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 1,080 | $13K | 2/12/2024 | View on chart |
| ENTA | ▲ Buy | Grant | 3,680 | $0 | 2/12/2024 | View on chart |
| ENTA | ▼ Sell | Open Market | 2,412 | $23K | 12/5/2023 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 1,595 | $15K | 12/1/2023 | View on chart |
| ENTA | ▲ Buy | Option Exercise | 13,925 | $195K | 3/15/2023 | View on chart |
| ENTA | ▼ Sell | Open Market | 269 | $12K | 3/15/2023 | View on chart |
| ENTA | ▼ Sell | Open Market | 13,656 | $607K | 3/15/2023 | View on chart |
| ENTA | ▲ Buy | Grant | 13,017 | $0 | 2/13/2023 | View on chart |
| ENTA | ▲ Buy | Grant | 10,250 | $0 | 2/13/2023 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 7,752 | $409K | 2/13/2023 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 1,055 | $47K | 12/1/2022 | View on chart |
| ENTA | ▲ Buy | Grant | 21,000 | $0 | 11/23/2022 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 953 | $60K | 2/14/2022 | View on chart |
| ENTA | ▲ Buy | Grant | 2,419 | $0 | 2/14/2022 | View on chart |
| ENTA | ▲ Buy | Grant | 615 | $0 | 2/14/2022 | View on chart |
| ENTA | ▼ Sell | Tax Withholding | 557 | $49K | 12/1/2021 | View on chart |
| ENTA | ▲ Buy | Grant | 6,800 | $0 | 11/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
HC Wainwright Maintains $20 Target for Enanta
HC Wainwright reiterated its stance on Enanta Pharmaceuticals, keeping a price target of $20. This view aligns with the broader analyst consensus, where the average target across six analysts is $21.83. The stock is currently trading near its 52-week low, with recent technical signals indicating support at $13.25.
HC Wainwright Maintains $20 Target for Enanta. HC Wainwright reiterated its stance on Enanta Pharmaceuticals, keeping a price target of $20. This view aligns with the broader analyst consensus, where the average target across six analysts is $21.83. The stock is currently trading near its 52-week low, with recent technical signals indicating support at $13.25.